["/markets/stocks/news/has-the-time-come-for-patience-to-finally-pay-6-insurance-stocks-with-potential-upside-of-up-to-34/articleshow/112913033.cms", "/markets/stocks/news/rapid-multimodal-logistics-shares-debut-with-23-premium-on-bse-sme-platform/articleshow/112913682.cms", "/markets/stocks/news/ril-bonus-ril-bonus-share-deep-tech-makeover-fails-to-move-target-prices-higher/articleshow/112915689.cms", "/markets/stocks/news/trading-of-tata-motors-dvr-shares-suspended-heres-why/articleshow/112915794.cms", "/markets/stocks/news/bharti-hexacom-shares-rally-6-after-citi-initiates-coverage-predicting-a-20-upside/articleshow/112917041.cms", "/markets/stocks/news/grse-shares-surge-up-to-7-on-signing-of-mou-with-nhidcl/articleshow/112918556.cms", "/markets/stocks/news/prestige-estates-launches-qip-to-raise-up-to-rs-5000-crore/articleshow/112913845.cms", "/markets/stocks/news/sugar-ethanol-stocks-surge-up-to-13-as-govt-set-to-lift-cap-on-sugar-diversion-for-ethanol-production/articleshow/112913816.cms", "/markets/stocks/news/hot-stocks-brokerages-on-ril-lupin-bharti-hexacom-and-sunteck-realty/articleshow/112912147.cms", "/markets/stocks/news/8-high-growth-indian-stocks-matching-william-j-oneils-investment-criteria/slideshow/112912325.cms", "/markets/stocks/news/spicejet-shares-slip-over-6-as-dgca-places-airline-under-enhanced-surveillance/articleshow/112914148.cms", "/markets/stocks/news/stock-radar-100-rally-in-1-year-this-pharma-company-gave-a-pole-flag-breakout-time-to-buy/articleshow/112895455.cms", "/markets/stocks/news/fii-buys-these-8-low-priced-stocks-gain-over-50-in-5-months/slideshow/112919572.cms", "/markets/stocks/news/nifty-target-raised-to-26820-7-new-conviction-stock-picks-prabhudas-lilladher/articleshow/112919136.cms", "/markets/stocks/news/unstoppable-bulls-sensex-nifty-scale-fresh-peaks-tracking-positive-global-cues/articleshow/112912654.cms", "/markets/stocks/news/itc-hul-and-dabur-among-11-stocks-with-buy-view-from-brokerages-post-q1-earnings/articleshow/112915338.cms", "/markets/stocks/news/natco-pharma-shares-jump-5-as-company-files-for-generic-cancer-drug-approval-with-usfda/articleshow/112916487.cms"]